A carregar...

Lean body weight and metformin are insufficient to prevent endometrial hyperplasia in mice harboring inactivating mutations in PTEN

OBJECTIVES: Obesity is a major risk factor for endometrial cancer. We evaluated whether obesity exacerbates progression of endometrial hyperplasia (EH) using the PRCre/+ PTENflox/+ mouse model and examined if the type-2-diabetes drug, metformin, could prevent EH. METHODS: Twenty obese (PRCre/+ PTEN...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncology
Main Authors: IGLESIAS, David A., ZHANG, Qian, CELESTINO, Joseph, SUN, Charlotte C., YATES, Melinda S., SCHMANDT, Rosemarie E., LU, Karen H.
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5285472/
https://ncbi.nlm.nih.gov/pubmed/27931017
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000450615
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!